Sie suchten nach: flare up (Englisch - Maltesisch)

flare up of old infections
re-attivazzjoni ta’ infezzjonijiet tal-passat

symptoms of infection and inflammation old infections may flare up
sintomi ta’ infezzjoni u infjammazzjoni infezzjonijiet tal-passat jistgħu jerġgħu joħorġu

ms also tends to flare up from time to time: this is called a relapse.
ms għandha tendenza li tiggrava minn ħin għal ieħor: dan jissejjaħ irkadar.

he flares up in rage
jisbel

for some people, gout attacks may flare up when starting certain medicines that control uric acid levels.
għal xi persuni, attakki tal-gotta jistgħu jirkadaw meta jinbdew ċertu mediċini li jikkontrollaw il- livelli ta’ uric acid.

a flare-up of symptoms related to an inactive infection in your body (immune reactivation);
aggravar ta’ sintomi relatati ma infezzjoni mhux attiva fil-ġisem (riattivazzjoni immunitarja)

if there are signs of a flare-up, treatment should revert to twice a day as above.
jekk ikun hemm sinjali ta’ żidiet f’daqqa, it-trattament għandu jerġa’ jinbidel għal darbtejn kuljum kif imsemmi hawn fuq.

relvar ellipta has been shown to reduce flare-ups of copd symptoms.
relvar ellipta ntwera li jnaqqas it-tifqigħat tas-sintomi ta’ copd.

when the symptoms flare up, it is called a relapse (also known as an exacerbation or an attack).
meta s-sintomi jiżdiedu, din tissejjaħ rikaduta (magħrufa wkoll bħala taħrix tal-marda jew attakk).

when these people start treatment, they may find that old, hidden infections flare up, causing signs and symptoms of inflammation.
meta dawn in- nies jibdew il-kura, jistgħu isibu li infezzjonijiet moħbija tal-passat jerġgħu joħorġu, u jikkawżaw sintomi ta’ nfammazzjoni.

the main measure of effectiveness was the number of flare-ups the patients had over a year.
il-kejl prinċipali tal- effikaċja kien in-numru ta’ żidiet f’daqqa li kellhom il-pazjenti matul sena.

in polyarticular juvenile idiopathic arthritis, it took longer for the disease to flare up in the patients continuing to receive orencia than those who switched to placebo.
fl-artrite idjopatika ġuvenili poliartikulari, għadda iktar żmien qabel ma l-marda reġgħet feġġet fil- pazjenti li kienu ngħataw orencia milli f’dawk li kienu qalbu għall-plaċebo.

in maintenance treatment, protopic was more effective than placebo at reducing the number of flare-ups.
fil-manteniment tat-trattament, protopic kien aktar effettiv mill-plaċebo fit-tnaqqis tan-numru ta’ żidiet f’daqqa.

chronic obstructive pulmonary disease (copd), to reduce the number of flare ups of symptoms.
marda kronika ostruttiva tal-pulmun (copd - chronic obstructive pulmonary disease), biex tnaqqas in- numru ta’ taħrix tas-sintomi.

7% of the individuals with ad in clinical trials with imvanex experienced a flare-up or worsening of their skin condition during the course of the trial.
7% tal-individwi b’ad fil-provi kliniċi b’imvanex kellhom aggravament f’daqqa jew aggravament tal- kundizzjoni tal-ġilda tagħhom matul il-kors tal-prova.

cinqaero reduces how often you have flare-ups of your asthma, helps you breathe better and decreases your asthma symptoms.
cinqaero jnaqqas kemm-il darba inti jkollok irkadar tal-ażżma tiegħek, jgħinek tieħu n-nifs aħjar, u jnaqqas is-sintomi tal-ażżma tiegħek.

in maintenance treatment, it is used in patients who usually have four or more flare- ups per year and who have had a response to an initial course of protopic used twice a day for up to six weeks.
fil-manteniment tat-trattament, jintuża f’pazjenti li normalment ikollhom erba’ żidiet f’daqqa jew aktar kull sena u li jkunu rrispondew għal kors inizjali ta’ protopic użat darbtejn kuljum sa sitt ġimgħat.

in rare cases upon withdrawal of yellox, a flare-up of the inflammatory response, e.g. in the form of retina swelling, due to the cataract operation has been observed.
f’ każijiet rari mal-irtirar ta’ yellox, aggravament tar-rispons infjammatorju, eż. fil-forma ta’ nefħa fir-retina, jista’ jseħħ minħabba l-operazzjoni tal-katarretti.

however, the study failed to show that quinsair is more effective than placebo at increasing the time it took before the patients had an exacerbation (flare-up) of their disease.
madankollu, l-istudju naqas milli juri li quinsair huwa aktar effikaċji minn plaċebo biex iżid il-ħin li l-pazjenti ħadu qabel kellhom aggravar (rikaduta) tal-marda tagħhom.

daliresp has been compared with placebo (a dummy treatment) in two main studies involving over 3,000 adults with severe copd who had had at least one flare-up of their disease in the past year.
daliresp tqabbel ma’ plaċebo (trattament finta) f’żewġ studji prinċipali li involvew aktar minn 3,000 adult b’copd severa li kellhom mill-anqas attakk wieħed tal-marda tagħhom fl-aħħar sena.